12/20/2021, 2:05 PM (Source: TeleTrader)
more TeleTrader news


Chart for: Novavax

EMA recommends authorization of Novavax COVID jab

The European Medicines Agency (EMA) said on Monday it is recommending Novavax's COVID-19 vaccine Nuvaxovid for a conditional marketing authorization in the European Union.

"After a thorough evaluation, EMA's human medicines committee (CHMP) concluded by consensus that the data on the vaccine were robust and met the EU criteria for efficacy, safety and quality," the agency stated and stressed the approval should be granted for the inoculation of people over 18 years of age.

The approval from the European Commission followed this decision, making Nuvaxovid the fifth COVID-19 vaccine used in the EU, joining jabs developed by Pfizer, Moderna, AstraZeneca and Johnson & Johnson.

Baha Breaking News (BBN) / NP